sábado, 19 de junio de 2010

HOW TO STOP PRESBYOPIA AND RECOVER VISION. HYPEROPIA AND PRESBYOPIA DROPS TREATMENT



ADVANCED TREATMENT TO RESTORE VISION.

   READ WITHOUT GLASSES NOR SURGERY   


HOW TO STOP PRESBYOPIA AND RECOVER VISION


 For over some decades ophthalmologists have been treating presbyopia with drugs with the aim of stopping it and helping patients to recover their vision.
The simplest non invasive treatment consists of using drops which give the eye back its aptitude to focus, the same way we could do when we were young without the need of glasses.
This medicine is obtained from a medicinal plant which was used by the aborigines of the north of Brazil before colonization.
The great majority of the patients who begin this treatment manage to drive, work, read, use the computer and write text messages without the need of glasses.
Due to the rising requirements of our society in general and of technological advances in particular, we have observed an increase in the demand of solutions to improve and preserve vision over the last years.

Our recommendation is to use preventive treatments which are neither invasive nor risky and to pay attention to some simple habits such as: being moderate with muscle relaxants and psychoactive drugs (sedatives and tranquilizers), wearing glasses for presbyopia as little as possible, reading using good quality light (if possible solar or incandescent) and avoiding wearing glasses while walking, including either bifocals or multifocals.


Preventive treatment
Successful research has been carried out for over the past decades on presbyopia and hyperopia treatment and some diseases of the accommodation and refraction of the eye.

As a result, significant progress has been made in the knowledge and treatment of diseases of the visual system (related to genetic influence as in the case of hyperopia or caused by aging as presbyopia) allowing to reduce or to stop the advancement of the loss of vision in a great number of people.
The preventive treatment is drug based. It has been used in research for over thirty years and at present is administered combining drugs.

It is a very simple method and it is the most appropriate one for those willing to stop wearing glasses.
The composition and dosage varies according to each particular case and is administered following medical evaluation.


In short, the idea is to find the solution for presbyopia and to preserve a good quality of vision during our entire life, which is both the wish of our patients and what is expected from us.

WHAT IS FARSIGHTEDNESS?

Hyperopia, also known as farsightedness, longsightedness or hypermetropia, is a defect of vision caused by an imperfection in the eye refraction which affects about 10 percent of population.
Hyperopia develops in eyes that focus images behind the retina instead of on the retina, which can result in blurred vision.
This occurs when the eyeball is too short, which prevents incoming light from focusing directly on the retina. It may also be caused by an abnormal shape of the cornea or lens.

Farsightedness often starts in early childhood. But normal growth corrects the problem. If a child is still a bit farsighted when the eye has stopped growing (at around 9 years of age), the eye can usually adjust to make up for the problem. This allows the child to see clearly. But as we age, our eyes can no longer adjust as well, and farsightedness becomes more obvious.
Symptoms and clasification
Young people with mild to moderate hyperopia are often able to see clearly because their natural lens can adjust, or accommodate to increase the eye’s focusing ability. However, as the eye gradually loses the ability to accommodate (beginning at about 40 years of age), blurred vision from hyperopia often becomes more apparent.

Symptoms depend on the degree of hyperopia. Some individuals may have no symptoms, while others have blurry near vision and clear distance vision, and those with the most severe cases have blurry near and distance vision. Headaches and eyestrain may also occur, particularly when doing close work.

People with hyperopia can experience blurred vision, asthenopia, accommodative dysfunction, binocular dysfunction, amblyopia, and strabismus.

Hyperopia is typically classified according to clinical appearance, its severity, or how it relates to the eye's accommodative status.

Various eye care professionals, including ophthalmologists, optometrists, orthoptists, and opticians, are involved in the treatment and management of hyperopia.

There is already a variety of existing methods, some drug based, others optical and surgical. All of them are used efficiently meeting the requirements of the different stages of the eye disorder, both prematurely working with prevention and later with recovery of the vision.

Minor amounts of hyperopia are sometimes left uncorrected. However, larger amounts may be corrected with convex lenses in eyeglasses or contact lenses. Convex lenses have a positive dioptric value, which causes the light to focus closer than its normal range.
Hyperopia is sometimes correctable with various refractive surgery procedures;LASIK or conductive keratoplasty. It can also be corrected with implanted special concave lenses.


Moreover, the benefits of this treatment are to avoid both the dependence on glasses and the rebound effect of glasses, to improve close and far vision and to recover or avoid blurred vision caused by some medicaments such as muscle relaxants and psychoactive drugs (sedatives and tranquilizers).

Thus, this treatment provides the great majority of its users the satisfaction of maintaining their vision in spite of years going by. And a great number of people who could only see properly wearing glasses or contact lenses can improve their vision significantly.

As regards present treatments which are optical or surgical, the administration of this medicament is helpful since it avoids progressive changes in the adjustment of glasses and prevents relapse of hyperopia in the post operation period.

As a preventive method, its efficacy varies according to the patient’s age when starting the treatment. Its strongest effect is between thirty five and sixty nine years old.
It can be administered among children and youngsters as well.
The duration of the treatment is optional and it depends on each individual; it can even be continued for a lifetime.
Stopping the treatment does not have unwanted effects and it is observed that the vision returns to the level at the starting point, according to the patient’s age and previous refraction.

In very few cases has the treatment been cancelled due to adverse effects such as allergic reactions in the conjunctiva or cephalea in hyperreactive patients.


Scientific base principles.
The ciliary muscle controls the shape of the lens through suspended suspensory ligaments called zonules. This provides the acomodation ability to the eye.
Like most smooth muscles, the ciliary muscle has a dual innervation, receiving both sympathetic and parasympathetic fibers.

In the ciliary muscle, the contraction necessary for accommodation is under parasympathetic control.
Most current theories of accommodation assume that the condition of physiological rest of accommodation occurs when the emmetropic eye focuses on a distant target, demanding good resolution.

Accordingly, in the natural resting state of the eye, the parasympathetic system maintains ciliary muscle tone, i.e., the ciliary muscle is contracted and zonular tension is relaxed such that the lens is more spherical and in a forward position increasing the refractive power of the eye. Thus, the eye is naturally in a “tonic accommodative” state and with appropriate stimulus is capable of further active positive accommodation.

Aging studies on the brain have demonstrated a loss of function of the parasympathetic system that is due to a decline in the neurotransmitter substance acetylcholine. This is probably due to a decreased production by the enzyme cholineacetyl transferate (CHAT) acetylcholine synthetase as there is no decline in parasympathetic receptor cells with age. That is, the ciliary muscle has the same number of receptors and the contractile ability of the muscle is the same in young and old individuals.
The administration of the lacking neurotransmitter or muscarinic agonist may restore the lost vision

This compounds are known in the art for their purposes, and are known to be safe under ordinary conditions of use.


(Traitement médical des vices de réfraction, in J. Sédan e altri, Thérapeutique médicale oculaire, Paris 1957, pp. 1228-1237).




HUGONNIER, R. – CLAYETTE-HUGONNIER, S. — STRABISMES, HETEROPHORIES, PARALISIS OCULOMOTRICES (les dese- quilibres oculo-moteurs en clinique). Paris, Masson, 1959 (554- 556) TRAITEMENT MÉDICAL GÉNÉRAL ET LOCAL

Thus, the treatment can be administered by substantially conventional means, consistent with known eye treatments, and while avoiding irritation, discomfort or the need of unusual application procedures.



Special offer of drops for presbyopia


TEST DROPS FOR PRESBYOPIA AND HYPEROPIA
People who would like to try the effect of this treatment will receive a bottle with the drops in the adequate doses without charge.  
In order to test the drops at your home, ask for instructions:
Email: argonzalezsantos@gmail.com
International dialing 549 11 60 23 64 07

DROPS TO SEE BETTER
Special treatment for presbyopia and hyperopia
You can prove that it is possible to read again without glasses. It can be done at your home or at our office in Buenos Aires
LIBERTAD 1173 PISO 2 ´´ A´´  C.A.B.A.  TEL. 48126239
http://www.consultoriosprofesionales.com/ficha.php?id=472
Tel. 
(011) 15 60 23 64 07
argonzalezsantos@gmail.com
BUENOS AIRES
 REPÚBLICA ARGENTINA



This way we offer the possibility to prove the quality of this treatment.


DURATION OF THE TEST AT OUR OFFICES
The test is between one and two hours long.
You can either ask for an appointment for this test without charge in any of our offices or have the drops delivered to your home and ask for instructions.

IN WHICH CASES SHOULDN’T THE TEST BE DONE?
When there is: 
Detachment of the retina
Maculopathy
Haemorrhage
Diabetic retinopathy 
Traumatism of the eye
Anterior or posterior uveitis 
Vitreous detachment 
Myopia higher than -1
Cataract
Migraine


 CONTACTS
-LIBERTAD 1173 PISO 2 ´´ A´´  C.A.B.A.  TEL. 48126239
http://www.consultoriosprofesionales.com/ficha.php?id=472
Tel.5491160236407 Local(011)1560236407
BUENOS AIRES.
REPÚBLICA ARGENTINA

Dr. Alejandro González Santos. Médico especialista en oftalmología.
Titular del CENTRO PARA LA VISION. Ex-jefe de sección del HOSPITAL OFTALMOLOGICO Dr. P. LAGLEYZE
Matrícula Nacional 47737 argonzalezsantos@gmail.com

sábado, 8 de mayo de 2010

DROPS FOR HYPEROPIA AND PRESBYOPIA

-->
Vision treatment
A serious choice
Nowadays patients are offered the benefit of maintaining a good vision quality without depending on glasses, without taking risks and, in most cases, without surgery and even at a reasonable cost.
RESEARCH
Successful research has been carried out for over the past decades on hyperopia treatment and some diseases of the accommodation and refraction of the eye.
As a result, significant progress has been made in the knowledge and treatment of diseases of the visual system (related to genetic influence as in the case of hyperopia or caused by aging as presbyopia) allowing to reduce or to stop the advancement of the loss of vision in a great number of people.
There is already a variety of existing methods, some drug based, others optical and surgical. All of them are used efficiently meeting the requirements of the different stages of the eye disorder, both prematurely working with prevention and later with recovery of the vision.
PREVENTIVE TREATMENT
The preventive treatment is drug based. It has been used in research for over thirty years and at present is administered combining drugs produced both locally and abroad. 

(Traitement médical des vices de réfraction, in J. Sédan e altri, Thérapeutique médicale oculaire, Paris 1957, pp. 1228-1237).

These medications are produced by medical national and multinational laboratories. They are available in pharmacies throughout the country. They are produced in compliance with international quality control and manufacture standards and they are backed by serious experimental and human based research.
It is a very simple method and it is the most appropriate one for those willing to stop wearing glasses.
The composition and dosage varies according to each particular case and is administered following medical evaluation.

HUGONNIER, R. – CLAYETTE-HUGONNIER, S. — STRABISMES, HETEROPHORIES, PARALISIS OCULOMOTRICES (les dese- quilibres oculo-moteurs en clinique). Paris, Masson, 1959 (554- 556) TRAITEMENT MÉDICAL GÉNÉRAL ET LOCAL




Variaciones de la Agudeza Visual luego de 
Administrar Pilocarpina y Tetrahidrozolina a 
Pacientes Hipermétropes
Dr. Alejandro González Santos
ARCH. OFTAL. B. AIRES;  vol 81 nº 2; pág 51-55; 2010

Purpose: To determine up to which extent visual acuity (VA) can be increased in hyperopic patients after extended administration of an association of cholinergic and alfa adrenergic drug.
Results: Visual acuity with no optical correction increased between 1 and 9 lines in the decimal scale at a distance of 6 meters compared to previous levels of VA of the patients before starting the treatment.

http://sao.org.ar/LinkClick.aspx?fileticket=6Ld8dL-HbfA%3D&tabid=492&language=es-AR



Benefits
Moreover, the benefits of this treatment are to avoid both the dependence on glasses and the rebound effect of glasses, to improve close and far vision and to recover or avoid blurred vision caused by some medicaments such as muscle relaxants and psychoactive drugs (sedatives and tranquilizers).
Thus, this treatment provides the great majority of its users the satisfaction of maintaining their vision in spite of years going by. And a great number of people who could only see properly wearing glasses or contact lenses can improve their vision significantly.
As regards present treatments which are optical or surgical, the administration of this medicament is helpful since it avoids progressive changes in the adjustment of glasses and prevents relapse of hyperopia in the post operation period.
As a preventive method, its efficacy varies according to the patient’s age when starting the treatment. Its strongest effect is between thirty five and fifty five years old. It starts to slowly decline between fifty five and sixty five years old.
It can be administered among children and youngsters as well.
Duration
The duration of the treatment is optional and it depends on each individual; it can even be continued for a lifetime.
Stopping the treatment does not have unwanted effects and it is observed that the vision returns to the level at the starting point, according to the patient’s age and previous refraction.
Adverse effects
In very few cases has the treatment been cancelled due to adverse effects such as allergic reactions in the conjunctiva or cephalea in hyperreactive patients.
Occasionally, a dose increase was decided in some hyporreactive patients, which enabled them to continue under treatment.
Costs
In pharmacies the medicament is just as expensive as any other first quality eye drop (such as artificial tears or antibiotics).


COMBINED TREATMENT OF LASER EXCIMER FOR PRESBYOPIC FARSIGHTEDNESS

We successfully combine the treatment of laser excímer for presbyopic farsightedness with the drops to see better.

The excimer laser is a surgical procedure, which because of its simplicity and low risk,       has become the most frequentely chosen surgical treatment to replace glasses and contact lenses by people who suffer myopia, farsightedness and astigmatism.
Improvement of visual acuity is achieved very rapidly. The result is stable in those who suffer from myopia and astigmatism and less stable in those who suffer from farsightedness.

It has been verified that, only a few years after having been operated for farsightedness, a great number of patients once again need optical help to read, work with the computer, read text messages or movies subtitles, watch TV or drive their car.
Moreover, after ten years of the first surgery, many of them need a second operation due to their low vision.

New and original treatment
We have been working with this combined treatment for over ten years.
The combined treatment of drops to see better and excímer laser may improve the prognosis of the laser excímer surgery for farsightedness, avoiding the relapse of farsightedness and presbyopia in the postoperative period for decades.

How does it work?
This effective treatment contains an association of two active principles, colinergic and adrenergic, which reestablishes and preserves the tone of accommodation for decades, as long as it is used regularly. It preserves visual acuity and the quality of close vision without needing glasses again.

When is it prescribed?
In young patients it prevents using non physiological treatments of mono-vision for distance vision with one eye and near vision with the other one and other more invasive methods.
This combined treatment is prescribed for most of the people who have undergone laser surgery for presbyopia or farsightedness and for low-reactive presbyopes whose visual acuity could not be improved adequately with other treatments.

Research:

http://www.sao.org.ar/N%C3%BAmeroActual/81_02_05/tabid/499/language/es-AR/Default.aspx

Contact:
Dr. Alejandro González Santos. M. D. Ophthalmologist
Matrícula Nacional 47737 argonzalezsantos@gmail.com
Dr. Eduardo González Santos. M. D. Ophthalmologist.
Matrícula Nacional 59920 oftalmologiagsantos@gmail.com
Dra. María Isabel Crestelo. M. D. Ophthalmologist.
Matrícula Nacional 73634 mariacrestelo@gmail.com.
http:// hyperopiaandpresbyopiatreatments.blogspot.com
Buenos Aires, April 2010
CONTACTS
 -LIBERTAD 1173 PISO 2 ´´ A´´  C.A.B.A.  TEL. 48126239
http://www.consultoriosprofesionales.com/ficha.php?id=472 Tel.5491160236407 Local(011)1560236407
BUENOS AIRES.
REPÚBLICA ARGENTINA

Dr. Alejandro González Santos. Médico especialista en oftalmología.
Titular del CENTRO PARA LA VISION. Ex-jefe de sección del HOSPITAL OFTALMOLOGICO Dr. P. LAGLEYZE
Matrícula Nacional 47737 argonzalezsantos@gmail.com